HomeGeneticsConditionSimpson-Golabi-Behmel syndrome
Back to Condition
Simpson-Golabi-Behmel syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Simpson-Golabi-Behmel syndrome

Simpson-Golabi-Behmel syndrome is an X-linked overgrowth condition characterized by distinctive facial features, skeletal abnormalities, and an increased risk of childhood tumors.

Overview

Simpson-Golabi-Behmel syndrome is a condition that affects many parts of the body and occurs primarily in males. It is classified as an overgrowth syndrome, meaning affected infants are considerably larger than normal at birth (macrosomia) and continue to grow and gain weight at an unusual rate. While symptoms vary widely, individuals with mild cases often live into adulthood.

Symptoms

The physical characteristics of the syndrome are diverse and can include:

  • Distinctive facial features: Widely spaced eyes, an unusually large mouth, a large tongue that may have a groove down the middle, a broad nose with an upturned tip, and abnormalities of the palate. In older children and adults, these features are often described as coarse.
  • Chest and abdominal abnormalities: Extra nipples, diastasis recti (an abnormal opening in the abdominal muscle), umbilical hernia, or a hole in the diaphragm that may crowd the heart and lungs.
  • Organ and skeletal issues: Heart defects, malformed or abnormally large kidneys, an enlarged liver and spleen (hepatosplenomegaly), and various skeletal abnormalities.
  • Developmental impact: Potential abnormalities affecting the development of the skeleton, kidneys, and genitalia. Intellectual disability ranging from mild to severe may occur, though some individuals have normal intelligence.
  • Tumor risk: Approximately 10 percent of affected individuals develop cancerous or noncancerous tumors in early childhood, most commonly Wilms tumor (a rare form of kidney cancer) or neuroblastoma.

Causes & Risk Factors

The most common cause is a mutation in the GPC3 gene, which provides instructions for making the protein glypican 3. This protein inhibits the hedgehog signaling pathway, which is critical for cell growth, specialization, and embryonic patterning. Mutations prevent this inhibition, leading to overactive signaling and increased cell proliferation.

Some individuals do not have an identified GPC3 mutation, and the cause remains unknown in these cases. A more severe, distinct disorder previously designated as Simpson-Golabi-Behmel syndrome type 2 (SGBS2) is now considered a separate condition.

Inheritance

This condition is inherited in an X-linked pattern. Because males have only one X chromosome, one altered copy of the gene is sufficient to cause the syndrome. Females have two X chromosomes; therefore, one altered copy usually results in less severe health problems or no symptoms at all, though some females may exhibit distinctive facial features, malformed fingernails, extra nipples, or skeletal abnormalities.

Frequently Asked Questions

Due to a significantly elevated risk of embryonic malignancies, especially Wilms tumor and neuroblastoma, children require structured surveillance from birth through early childhood. Standard protocols include abdominal and renal ultrasounds alongside serum alpha-fetoprotein (AFP) testing every 3 months until age 4, followed by renal ultrasounds every 3 to 6 months until approximately age 7 to 8. Clinicians also periodically monitor urinary catecholamines to screen for neuroblastoma.
Simpson-Golabi-Behmel syndrome is linked to the X chromosome, so males who inherit the GPC3 mutation generally experience full clinical manifestations. Female carriers possess one mutated and one normal X chromosome; they often have subtle physical signs like mild facial coarsening or extra nipples, but rarely severe internal defects. A carrier female has a 50 percent chance in each pregnancy of passing the variant to a son, who will be affected, or to a daughter, who will also be a carrier.
Structural congenital heart defects and progressive cardiomyopathy are frequent and potentially life-threatening in Simpson-Golabi-Behmel syndrome. Affected newborns should receive an early baseline echocardiogram and electrocardiogram (ECG) to screen for conditions such as ventricular septal defects, patent ductus arteriosus, and arrhythmias. Regular cardiac follow-ups are critical to prevent heart failure and to safely plan any needed surgeries, such as repairs for cleft palate or abdominal hernias.
Yes, infants with this condition are at elevated risk for neonatal hypoglycemia, often driven by transient hyperinsulinism associated with overgrowth. Blood glucose levels must be monitored closely in the newborn nursery. Hypoglycemia is managed with frequent, high-calorie feedings or intravenous glucose infusions. If low blood sugar persists, targeted medications such as diazoxide may be prescribed under endocrinological supervision to protect developing brain tissue.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA